ESC Action Center
Welcome to the ESC Action Center, where you’ll find breaking news and insights from the European Society of Cardiology (ESC) Congress. Explore pivotal presentations, innovative research findings, and emerging treatments to stay at the forefront of the latest advancements in cardiology.
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
CME/CE Broadcast ReplayOptimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
Iacopo Olivotto, MD
Ahmad Masri, MD, MS
Pablo Garcia-Pavia, MD, PhD
Fabian Knebel, MD, PhD
Caroline Coats, MD
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
CME/CE Broadcast ReplayCrossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
Prof. Ulrich Laufs
Pam R. Taub, MD, FACC, FASPC
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Christie Ballantyne, MD
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast ReplayNew Insights in the Management of HCM: Exploring the Clinical Spectrum
Milind Y. Desai, MD, MBA
Iacopo Olivotto, MD
Elena Arbelo, MD, PhD
- advertisement
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Heart MattersReducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Stephanie Dixon, MD, MPH
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Heart MattersAdapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart MattersA Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Bruno Batinica, MD
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
- advertisement
- 09/01/2024